Results 1 to 10 of about 876,914 (305)
Causes of venous thrombosis [PDF]
Venous thrombosis which mainly manifests as deep vein thrombosis of the leg or pulmonary embolism occurs in 1 per 1000 per year. It occurs due to interacting genetic, environmental and behavioral risk factors. The strongest risk factors are certain types
F. Rosendaal
semanticscholar +3 more sources
Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The most vulnerable populations include young individuals, women of reproductive age, and patients with a prothrombotic state.
G. Saposnik +11 more
exaly +2 more sources
Deep vein thrombosis initiation is mediated by cross talk between monocytes, neutrophils, and platelets.
Robert Byrne +2 more
exaly +2 more sources
Venous thrombosis in neonates [PDF]
The incidence of thrombotic disorders in neonates and children is increasing with advances in diagnostic modalities, supportive care, and management of many health conditions. The developing coagulation system, need for intensive care, including catheterization, and co-morbid conditions are responsible for the relatively high risk of thrombosis in ...
Bhatt, Mihir D, Chan, Anthony KC
openaire +2 more sources
Superior Mesenteric Venous Thrombosis Presenting with Hematemesis: A Case Report
The superior mesenteric vein (SMV) is one of the two tributaries to the portal vein, which is the main pre-hepatic drainage channel of the splanchnic circulation.
Edward Mackutwa +3 more
doaj +1 more source
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera
We investigated the neutrophil-to-lymphocyte ratio (NLR) as a predictor of thrombosis in polycythemia vera (PV). After a median follow-up of 2.51 years, of 1508 PV patients enrolled in the ECLAP study, 82 and 84 developed arterial and venous thrombosis ...
A. Carobbio +10 more
semanticscholar +1 more source
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Background A new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged as a rare side-effect of vaccination against COVID-19.
R. Perry +76 more
semanticscholar +1 more source
P‐ and E‐ selectin in venous thrombosis and non‐venous pathologies
Venous thromboembolism is a very common and costly health problem worldwide. Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding, and none prevent the development of post thrombotic syndrome after deep vein ...
Megan Purdy +3 more
semanticscholar +1 more source
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection predisposes patients to arterial and venous thrombosis. This study aimed to systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) in ...
Tommaso Baldini +8 more
semanticscholar +1 more source
Thrombotic events are the most frequent manifestations of essential thrombocythemia (ET). The objective of this study is to determine the incidence of thrombosis at different sites on follow-up in patients with ET. We searched PubMed, Web of Science, and
Dehao Wang MD +13 more
doaj +1 more source

